(Q35906322)

11 August 2017

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients (English)

1 reference

11 August 2017

7

Hiroji Iwata

1 reference

11 August 2017

Tatsuya Toyama

1

1 reference

11 August 2017

Zhenhuan Zhang

2

1 reference

11 August 2017

Mariko Nishio

3

1 reference

11 August 2017

Maho Hamaguchi

4

1 reference

11 August 2017

Naoto Kondo

5

1 reference

11 August 2017

Hirotaka Iwase

6

1 reference

11 August 2017

Satoru Takahashi

8

1 reference

11 August 2017

Hiroko Yamashita

9

1 reference

11 August 2017

Yoshitaka Fujii

10

1 reference

11 August 2017

1 January 2007

1 reference

11 August 2017

Breast Cancer Research

1 reference

11 August 2017

9

1 reference

11 August 2017

R34

1 reference

11 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr1682

11 August 2017

0 references

cites work

A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Repeated observation of breast tumor subtypes in independent gene expression data sets

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

The p53-Mdm2 module and the ubiquitin system.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

11 July 2018

Surfing the p53 network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Two polymorphic variants of wild-type p53 differ biochemically and biologically

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

p53, the cellular gatekeeper for growth and division

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Primary structure polymorphism at amino acid residue 72 of human p53.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

11 July 2018

1 reference

Immunohistochemical status of p53, MDM2, bcl2, bax, and ER in invasive ductal breast carcinoma in Tunisian patients.

21 January 2018

1 reference

p53 polymorphic variants at codon 72 exert different effects on cell cycle progression

21 January 2018

1 reference

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer

21 January 2018

1 reference

p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients.

21 January 2018

1 reference

p53 polymorphisms and haplotypes in breast cancer.

21 January 2018

1 reference

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

21 January 2018

1 reference

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

21 January 2018

1 reference

No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites

21 January 2018

1 reference

The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.

21 January 2018

1 reference

TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer

21 January 2018

1 reference

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

21 January 2018

1 reference

p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis.

21 January 2018

1 reference

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

21 January 2018

1 reference

p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome

24 September 2018

1 reference

Association of breast cancer outcome with status of p53 and MDM2 SNP309

21 January 2018

1 reference

12 December 2020

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas

1 reference

12 December 2020

p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma

1 reference

12 December 2020

Abnormal expression of MDM-2 in breast carcinomas

1 reference

12 December 2020

Genotype phenotype correlations in Israeli colorectal cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR1682

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference